Democratic Leader Pelosi, Rep. Waxman, Rep. George Miller, Rep. Obey, and Rep. Cummings write the President about three recent incidents in which taxpayer funds have been improperly used by Administration officials to pay for covert efforts to influence public opinion.
Rep. Waxman and Sen. Conrad ask Agriculture nominee Michael Johanns to reconsider the decision to allow cattle imports from Canada in light of new information that cattle feed in Canada may be contaminated with animal protein, risking the spread of “mad cow disease.”
Rep. Waxman and Chairman Davis write Secretary Thompson to object to a plan to use CDC's child immunization funds to purchase flu vaccine from abroad.
Despite nine critical government audits, whistleblower testimony describing egregious overbilling, and criminal investigations into kickbacks and overcharging, Halliburton has been awarded $10.8 billion under its Iraq contracts.
Rep. Waxman requests a GAO investigation into AIDS prevention activities funded by the President's Emergency Plan for AIDS Relief (PEPFAR).
Reps. Waxman, Obey, and Dingell describe their concerns with a new ethics policy that restricts the right of members to criticize the Ethics Committee.
Acting FDA Commissioner Dr. Lester Crawford's testimony maintained that FDA made no mistakes that contributed to the flu vaccine crisis, but a review of the record reveals conflicting evidence from FDA documents, statements made by senior FDA staff, and basic facts about FDA's regulatory system.
Rep. Waxman and Chairman Davis request information on NIH's policies regarding conflicts of interest for researchers who receive NIH grants and scientists who review grant proposals.
Rep. Waxman asks FDA to review the discrepancy between claims made by AstraZeneca that FDA has “no concern” about the safety of the drug Crestor, in light of top FDA officials’ statements that FDA is “very concerned” and is closely evaluating the drug.
A report released by Rep. Waxman shows that many federally funded abstinence-only education programs use curricula that distort information about the effectiveness of contraceptives, misrepresent the risks of abortion, blur religion and science, treat stereotypes about girls and boys as scientific fact, and contain basic scientific errors.
New FDA documents raise serious questions about the agency’s oversight of the Chiron facility that was scheduled to deliver half of the nation’s flu shot supply this year.
Rep. Waxman calls for hearings into new State Department documents that disclose efforts by senior Administration officials, including the Ambassador to Kuwait, to steer a lucrative Halliburton fuel subcontract to a favored Kuwaiti company. The documents also describe allegations of widespread bribes and kickbacks sought by Halliburton officials.
Rep. Waxman asks FDA Commissioner Crawford to respond to a confidential communication received from inside his agency indicating that the Commissioner’s office is withholding documents that address whether the flu vaccine crisis could have been prevented.
Rep. Waxman writes Senate Majority Leader Frist and House Speaker Hastert to urge them to reject a last-minute effort to insert provisions undermining financial disclosure laws in the 9/11 legislation.
Rep. Waxman criticizes FDA for failing to release key documents about whether the flu vaccine crisis could have been prevented and asks Chairman Davis to issue an immediate subpoena.
A new report released by Rep. Waxman finds that the President has repeatedly appointed individuals with Republican political backgrounds to serve as nonpartisan Inspectors General at federal departments and agencies.
Reps. Waxman and Maloney ask GAO to investigate whether the Defense Department is fulfilling its obligation to ensure that Americans living abroad, both military and civilian, can vote.
Rep. Waxman releases four new fact sheets that explain (1) how the Administration ignored years of expert recommendations on vaccine supply; (2) how the Administration failed to invest in efforts to strengthen the vaccine supply, (3) how FDA failed to respond to warning signs at the contaminated facility; and (4) how liability concerns are irrelevant to the current crisis.
Rep. Waxman and Chairman Davis ask the Federal Trade Commission to examine reports that some distributors are charging exorbitant prices for the flu vaccine.
Rep. Turner, Ranking Member on the Select Committee on Homeland Security, and Rep. Waxman release an updated analysis that compares the 41 recommendations made by the 9/11 Commission to H.R. 10, the legislation developed by House Republican leadership and passed by the House on October 8.
A new audit by the International Advisory and Monitoring Board finds that the Bush Administration has not properly accounted for the expenditure of hundreds of millions of dollars in Iraqi oil proceeds.
Rep. Waxman asks the EPA Inspector General to investigate the influence of political considerations on an EPA report that concludes that "hydraulic fracturing" of oil and gas wells, an extraction technique promoted by Halliburton, does not pose a risk to drinking water.
A new GAO report released by Reps. Waxman and Conyers finds that the Justice Department is not prepared to respond to reports of voter intimidation and disenfranchisement in next month’s elections.
Rep. Waxman and Chairman Davis ask for the release of documents detailing what FDA knew about problems at the manufacturing facility that was shut down last week by British regulators, triggering the flu vaccine shortage.
A new report released by Rep. Waxman finds that thousands of disabled veterans in Southern California wait months before receiving veteran’s disability benefits.
Displaying Items 826 to 850 of 1351:
[1] • [2] • [3] • [4] • [5] • [6] • [7] • [8] • [9] • [10] • [11] • [12] • [13] • [14] • [15] • [16] • [17] • [18] • [19] • [20] • [21] • [22] • [23] • [24] • [25] • [26] • [27] • [28] • [29] • [30] • [31] • [32] • [33] • [34] • [35] • [36] • [37] • [38] • [39] • [40] • [41] • [42] • [43] • [44] • [45] • [46] • [47] • [48] • [49] • [50] • [51] • [52] • [53] • [54] • [55]